We address every phase in the vitiligo drug discovery process, from basic research all the way to the clinic, in order for new treatments to reach patients. At the Vitiligo Research Foundation, we have only one incentive: to bring a vitiligo treatment to market for the dozens of millions of devastated patients worldwide.
Our inter-disciplinary research model considers all elements of the basic and clinical research, drug discovery and drug development value chain. More details on budget-minded pursuit of vitiligo therapy development here »
There is no global coordination of R&D in rare diseases generally and less so for vitiligo. It turns out that knowledge is one of the most difficult things to disseminate, even in the absence of explicit intellectual property rights. Existing structures may often be insufficient to provide knowledge efficiently and equitably at the global level.
We invite open minded investigators to participate in vitiligo research coordination. Your suggestions and ideas may improve lives of millions of affected people.
Learn more about ROUNDTABLE ON VITILIGO to join efforts.
VR Foundation supports vitiligo research across the biomedical spectrum, from fundamental lab-based science to clinical trials. VRF is proud for its low administrative costs and the high percentage of funds that are available to support its primary mission.
More on Vitiligo Research Funding »
CENTERS OF EXCELLENCE
VRF is committed to creating regional Centers of Excellence (CoE) in vitiligo that provide the latest technology solutions, privacy, cost competence, a high level of consistency professional quality management, new intellectual property, ethical and legal compliance. The establishment of CoEs provides efficient access to local collections of biological samples and associated clinical data for advanced research in vitiligo, which otherwise would have been impossible. More »
The Vitiligo Biobank is a networked repository of biomaterial and related clinical data contributed by vitiligo patients to help advance research. VRF facilitates access to biomaterial with specific characteristics that matches the intended research purpose. Read more » or visit website »
The following publications have resulted from or have been supported with grants from the VR Foundation: Read »
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
Is it possible to stop the progression of vitiligo?
Vitiligo is progressive in 73% of cases and regressive in 1.3%. We usually explain to the patients that progression depends on the modality of the disease spreading: l...
How can I treat vitiligo?
Choosing a treatment for vitiligo can be difficult, sometimes overwhelming. In general, first-line therapy should be safe, effective, minimally invasive, and cost effi...
What causes vitiligo?
It remains unclear what causes damage to melanocytes and their subsequent total inactivation and/or disappearance in vitiligo skin. There are several theories; the mos...
I have vitiligo: will my children have vitiligo, too?
Although most cases of vitiligo are sporadic, familial clustering is not uncommon, and up to 20% of patients report on the affected relatives. In whites, the lifetime ...